about
Genome-wide association study identified PLCE1- rs2797992 and EGFR- rs6950826 were associated with TP53 expression in the HBV-related hepatocellular carcinoma of Chinese patients in GuangxiCXCL4 Contributes to the Pathogenesis of Chronic Liver Allograft Dysfunction.EGFR rs11506105 and IFNL3 SNPs but not rs8099917 are strongly associated with treatment responses in Iranian patients with chronic hepatitis C.Chemotherapy for Hepatocellular Carcinoma: Current Evidence and Future PerspectivesRisk factors and prevention of hepatocellular carcinoma in the era of precision medicine.Hepatocellular carcinoma treated with anti-epidermal growth factor receptor antibody nimotuzumab: A case reportEDG2 enhanced the progression of hepatocellular carcinoma by LPA/PI3K/AKT/ mTOR signaling.β-defensin 1 expression in HCV infected liver/liver cancer: an important role in protecting HCV progression and liver cancer developmentPolychlorinated biphenyls disrupt hepatic epidermal growth factor receptor signaling.Overexpression of SCAMP3 is an indicator of poor prognosis in hepatocellular carcinoma.A model of dormant-emergent metastatic breast cancer progression enabling exploration of biomarker signatures.Epidermal Growth Factor Receptor Signaling Disruption by Endocrine and Metabolic Disrupting Chemicals.A simple in silico strategy identifies candidate biomarkers for the diagnosis of liver fibrosis in morbidly obese subjects.A novel strategy of profiling the mechanism of herbal medicines by combining network pharmacology with plasma concentration determination and affinity constant measurement.Silibinin Inhibits NSCLC Metastasis by Targeting the EGFR/LOX Pathway.Long-term treatment with EGFR inhibitor erlotinib attenuates renal inflammatory cytokines but not nephropathy in Alport syndrome mouse model.The role of propranolol as a radiosensitizer in gastric cancer treatment.ADAM17 is essential for ectodomain shedding of the EGF-receptor ligand amphiregulin.
P2860
Q36879598-1AE7178E-2876-4613-9DB2-5B38F3ADC2C8Q37526953-088ECF56-EFB2-4FD5-8C74-D7DE1CF4EC72Q40124597-4403555E-BC36-405B-9B33-EB89F006EE43Q41706847-15680B09-A6E8-4D07-9867-0555043D71ACQ41921861-E06B5263-3B7C-48F7-B04F-E59ED2FC092BQ41952696-6863F097-FA71-4249-B69D-5AFED96F9268Q42371617-B0783BEF-81BE-4A8B-8CC1-7FC6351A74B3Q42683902-128E3F53-7A65-4300-8AB7-607602BC0AA0Q47187755-A6DF2599-84F6-4446-8FEB-53CBDF20D5F2Q47193711-02D42137-62A6-4846-9E12-CF1DDE4672FDQ47558500-9528F200-7AD0-4A51-BF08-5923A1E596CFQ47656937-D438E555-19ED-4B54-9060-2844BE3C865DQ48222622-3DAF3261-F8E1-423E-A248-C7922091BA61Q48970633-DCFB0F12-EBA5-47E9-912A-D6F5339B20A5Q50218607-10AE4323-29FD-499A-8F42-5D2F60F9F409Q51147438-BDF3AB0A-D8C8-44D8-8BB4-64B3C79D9FACQ52595303-0F73D3E7-3673-4CBE-9C22-EAC83A57623EQ53831425-AF2D7FF2-9670-4A26-ACED-997C4500A52A
P2860
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
EGFR Signaling in Liver Diseases
@ast
EGFR Signaling in Liver Diseases
@en
EGFR Signaling in Liver Diseases
@nl
type
label
EGFR Signaling in Liver Diseases
@ast
EGFR Signaling in Liver Diseases
@en
EGFR Signaling in Liver Diseases
@nl
prefLabel
EGFR Signaling in Liver Diseases
@ast
EGFR Signaling in Liver Diseases
@en
EGFR Signaling in Liver Diseases
@nl
P2860
P921
P356
P1476
EGFR Signaling in Liver Diseases
@en
P2093
Karin Komposch
P2860
P356
10.3390/IJMS17010030
P407
P577
2015-12-29T00:00:00Z
2016-01-01T00:00:00Z